Summary of anti-SK results and ASOT/ADB titres in the study group (n = 47)
| Indigenous | Non-indigenous | Total | p Value | |
|---|---|---|---|---|
| ADB, anti-DNAse B antibodies; ASOT, antistreptolysin O antibodies; NS, not significant; SK, streptokinase. | ||||
| Positive ASOT/ADB titres | 14/19 (74%) | 4/28 (14%) | 18/47 (38%) | <0.001 |
| Positive anti-SK | 14/19 (74%) | 7/28 (25%) | 21/47 (45%) | <0.001 |
| Equivocal anti-SK | 3/19 (16%) | 4/28 (14%) | 7/47 (15%) | NS |
| Negative anti-SK | 2/19 (10%) | 17/28 (61%) | 19/47 (40%) | <0.001 |